Manufacturing

Balancing Retrofitting and New Builds in Pharmaceutical Manufacturing
Biotech & Bioprocessing Balancing Retrofitting and New Builds in Pharmaceutical Manufacturing

Ivan Kairatov is a Biopharma expert, with deep knowledge of tech and innovation in the industry and experience in research and development. Today, we will be discussing the Medicines Manufacturing Centre (MMC) project in the U.K., the increasing demand for monoclonal antibodies (mAbs) and advanced

March 13, 2025
Global Single-Use Bioprocessing Connectors Market Forecast to 2034
Biotech & Bioprocessing Global Single-Use Bioprocessing Connectors Market Forecast to 2034

The single-use bioprocessing connectors market is witnessing an unprecedented surge, revolutionizing the realm of biopharmaceutical production across the globe. This article delves into the multifaceted dynamics driving this market growth, exploring its crucial segments, regional variations, and

March 11, 2025
Can Europe's Medical Gloves Market Overcome Environmental Challenges?
Management & Regulatory Can Europe's Medical Gloves Market Overcome Environmental Challenges?

The Europe medical gloves market, valued at USD 4.35 billion in 2024, is set to grow steadily, reaching USD 7.89 billion by 2033. As healthcare demands rise, so does the reliance on medical gloves—a critical component in infection control. However, environmental concerns loom large over this b

March 10, 2025
Can Danaher Lead the Biopharma Sector With Innovations and Biosimilars?
Biotech & Bioprocessing Can Danaher Lead the Biopharma Sector With Innovations and Biosimilars?

As the landscape of biopharmaceutical manufacturing undergoes significant changes, Danaher Corporation stands at a pivotal crossroads with the potential to lead through its innovative strategies and products. At the TD Cowen Health Care Conference, Danaher President and CEO Rainer Blair emphasized

March 7, 2025
How Will Repligen's Acquisition of 908 Devices Enhance Bioprocessing?
Biotech & Bioprocessing How Will Repligen's Acquisition of 908 Devices Enhance Bioprocessing?

Repligen, an innovative leader in bioprocess technology, has made a strategic move by acquiring essential upstream Process Analytical Technology (PAT) assets from 908 Devices for a total of $70 million. This acquisition should be viewed as more than just a simple addition of technology; it

March 6, 2025
CDMO Sector Faces Challenges and Opportunities Amid 2024 Market Shifts
Management & Regulatory CDMO Sector Faces Challenges and Opportunities Amid 2024 Market Shifts

The Contract Development and Manufacturing Organization (CDMO) sector is navigating a landscape marked by significant changes and evolving trends. Gil Roth, President of the Pharma & Biopharma Outsourcing Association, provides a comprehensive analysis of the sector's current state and

February 10, 2025
Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later